Holly Kathleen Emerson

Title: The Innovative Contributions of Holly Kathleen Emerson

Introduction

Holly Kathleen Emerson is a distinguished inventor based in Durham, NC (US). She has made significant contributions to the field of pharmaceuticals, holding a total of 3 patents. Her work focuses on developing innovative compounds and methods that have the potential to impact medical treatments.

Latest Patents

Among her latest patents is the invention of 2-pyrimidinyl pyrazolopyridine ErbB kinase inhibitors. This invention provides 2-pyrimidinyl pyrazolopyridine compounds, compositions containing the same, as well as processes for their preparation and use as pharmaceutical agents. Another notable patent is the crystal structure of the liganded cFMS kinase domain. This patent details a crystal structure of the cFMS kinase domain, co-crystal structure with a bound small molecule, and methods for using this information in the discovery of cFMS inhibitors and in treating diseases mediated by inappropriate cFMS activity.

Career Highlights

Holly has worked with prominent companies in the pharmaceutical industry, including SmithKline Beecham Corporation and GlaxoSmithKline LLC. Her experience in these organizations has allowed her to develop her expertise and contribute to groundbreaking research.

Collaborations

Throughout her career, Holly has collaborated with notable professionals such as Stanley Dawes Chamberlain and Douglas McCord Sammond. These collaborations have further enriched her work and expanded her impact in the field.

Conclusion

Holly Kathleen Emerson's innovative contributions to pharmaceutical research and her impressive portfolio of patents highlight her role as a leading inventor in her field. Her work continues to pave the way for advancements in medical treatments and therapies.